Target intelligence / Profile preview

Sterol C-5 desaturase (ERG3) (ERG3)

Target
ERG3
Molecular classification
Enzyme, Oxidoreductase
01

Overview

Sterol C-5 desaturase, primarily known as ERG3 in fungal species, is a critical enzyme within the ergosterol biosynthesis pathway responsible for introducing a double bond at the C-5 position of the sterol nucleus (UniProt: P32353). Ergosterol is an essential component of fungal cell membranes, performing functions similar to cholesterol in humans by regulating membrane fluidity, permeability, and the function of membrane-bound proteins (NCBI Gene: 855700). This enzyme is a significant target in antifungal research because its inhibition or dysfunction disrupts the production of ergosterol, leading to compromised cell membrane integrity and inhibited fungal growth. Interestingly, ERG3 is also a major player in antifungal resistance; mutations that inactivate ERG3 allow fungi to bypass the lethal accumulation of toxic sterols typically caused by azole drugs, which target the upstream enzyme ERG11 (PMID: 21633012). In humans, the orthologous enzyme is Sterol-C5-desaturase (SC5D), and its deficiency is linked to the rare metabolic disorder lathosterolosis, highlighting the need for high selectivity in antifungal drug design (UniProt: Q15884; PMID: 10430571). Consequently, Sterol C-5 desaturase represents both a vulnerability in fungal pathogens and a complex factor in the evolution of clinical drug resistance.

Other names
C-5 sterol desaturaseErgosterol biosynthesis protein 3ERG3pSterol C-5(6) desaturaseSC5D
02

Mechanism of action

Inhibition of the C-5(6) desaturation of episterol to ergosta-5,7,24(28)-trien-3β-ol, leading to ergosterol depletion and accumulation of atypical sterols that disrupt membrane integrity.

03

Biological functions

Ergosterol biosynthesisSterol metabolic processMembrane organization and maintenance
04

Disease associations

Fungal infectionCandidiasisAspergillosisLathosterolosis (human homolog deficiency)
05

Safety considerations

Potential cross-reactivity with human Sterol C-5 desaturase (SC5D)Rapid emergence of antifungal resistance via loss-of-function mutations in the ERG3 gene
06

Interacting drugs

Fluconazole (indirect interaction via resistance mechanism)

2 more in the full profile.

07

Biomarkers

Ergosterol concentrationEpisterol accumulationLathosterol levels (human homolog)

Beyond the preview

Go deeper on Sterol C-5 desaturase (ERG3) (ERG3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sterol C-5 desaturase (ERG3) (ERG3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call